202 related articles for article (PubMed ID: 37523551)
1. Activin E-ACVR1C cross talk controls energy storage via suppression of adipose lipolysis in mice.
Adam RC; Pryce DS; Lee JS; Zhao Y; Mintah IJ; Min S; Halasz G; Mastaitis J; Atwal GS; Aykul S; Idone V; Economides AN; Lotta LA; Murphy AJ; Yancopoulos GD; Sleeman MW; Gusarova V
Proc Natl Acad Sci U S A; 2023 Aug; 120(32):e2309967120. PubMed ID: 37523551
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Activin E mediates liver-adipose inter-organ communication, suppressing adipose lipolysis in response to elevated serum fatty acids.
Griffin JD; Buxton JM; Culver JA; Barnes R; Jordan EA; White AR; Flaherty SE; Bernardo B; Ross T; Bence KK; Birnbaum MJ
Mol Metab; 2023 Dec; 78():101830. PubMed ID: 38787338
[TBL] [Abstract][Full Text] [Related]
3. Rare loss of function variants in the hepatokine gene INHBE protect from abdominal obesity.
Deaton AM; Dubey A; Ward LD; Dornbos P; Flannick J; ; Yee E; Ticau S; Noetzli L; Parker MM; Hoffing RA; Willis C; Plekan ME; Holleman AM; Hinkle G; Fitzgerald K; Vaishnaw AK; Nioi P
Nat Commun; 2022 Jul; 13(1):4319. PubMed ID: 35896531
[TBL] [Abstract][Full Text] [Related]
4. Human ACVR1C missense variants that correlate with altered body fat distribution produce metabolic alterations of graded severity in knock-in mutant mice.
Tangseefa P; Jin H; Zhang H; Xie M; Ibáñez CF
Mol Metab; 2024 Mar; 81():101890. PubMed ID: 38307384
[TBL] [Abstract][Full Text] [Related]
5. Activin E Controls Energy Homeostasis in Both Brown and White Adipose Tissues as a Hepatokine.
Hashimoto O; Funaba M; Sekiyama K; Doi S; Shindo D; Satoh R; Itoi H; Oiwa H; Morita M; Suzuki C; Sugiyama M; Yamakawa N; Takada H; Matsumura S; Inoue K; Oyadomari S; Sugino H; Kurisaki A
Cell Rep; 2018 Oct; 25(5):1193-1203. PubMed ID: 30380411
[TBL] [Abstract][Full Text] [Related]
6. Activin receptor-like kinase 7 suppresses lipolysis to accumulate fat in obesity through downregulation of peroxisome proliferator-activated receptor γ and C/EBPα.
Yogosawa S; Mizutani S; Ogawa Y; Izumi T
Diabetes; 2013 Jan; 62(1):115-23. PubMed ID: 22933117
[TBL] [Abstract][Full Text] [Related]
7. Activin receptor ALK4 promotes adipose tissue hyperplasia by suppressing differentiation of adipocyte precursors.
Lee ES; Guo T; Srivastava RK; Shabbir A; Ibáñez CF
J Biol Chem; 2023 Jan; 299(1):102716. PubMed ID: 36403856
[TBL] [Abstract][Full Text] [Related]
8. Insulin Regulates Lipolysis and Fat Mass by Upregulating Growth/Differentiation Factor 3 in Adipose Tissue Macrophages.
Bu Y; Okunishi K; Yogosawa S; Mizuno K; Irudayam MJ; Brown CW; Izumi T
Diabetes; 2018 Sep; 67(9):1761-1772. PubMed ID: 29945891
[TBL] [Abstract][Full Text] [Related]
9. Adipocyte ALK7 links nutrient overload to catecholamine resistance in obesity.
Guo T; Marmol P; Moliner A; Björnholm M; Zhang C; Shokat KM; Ibanez CF
Elife; 2014 Aug; 3():e03245. PubMed ID: 25161195
[TBL] [Abstract][Full Text] [Related]
10. Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes.
Akbari P; Sosina OA; Bovijn J; Landheer K; Nielsen JB; Kim M; Aykul S; De T; Haas ME; Hindy G; Lin N; Dinsmore IR; Luo JZ; Hectors S; Geraghty B; Germino M; Panagis L; Parasoglou P; Walls JR; Halasz G; Atwal GS; ; ; Jones M; LeBlanc MG; Still CD; Carey DJ; Giontella A; Orho-Melander M; Berumen J; Kuri-Morales P; Alegre-Díaz J; Torres JM; Emberson JR; Collins R; Rader DJ; Zambrowicz B; Murphy AJ; Balasubramanian S; Overton JD; Reid JG; Shuldiner AR; Cantor M; Abecasis GR; Ferreira MAR; Sleeman MW; Gusarova V; Altarejos J; Harris C; Economides AN; Idone V; Karalis K; Della Gatta G; Mirshahi T; Yancopoulos GD; Melander O; Marchini J; Tapia-Conyer R; Locke AE; Baras A; Verweij N; Lotta LA
Nat Commun; 2022 Aug; 13(1):4844. PubMed ID: 35999217
[TBL] [Abstract][Full Text] [Related]
11. DNA Sequence Variation in
Emdin CA; Khera AV; Aragam K; Haas M; Chaffin M; Klarin D; Natarajan P; Bick A; Zekavat SM; Nomura A; Ardissino D; Wilson JG; Schunkert H; McPherson R; Watkins H; Elosua R; Bown MJ; Samani NJ; Baber U; Erdmann J; Gupta N; Danesh J; Saleheen D; Gabriel S; Kathiresan S
Diabetes; 2019 Jan; 68(1):226-234. PubMed ID: 30389748
[TBL] [Abstract][Full Text] [Related]
12. GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism.
Boer GA; Keenan SN; Miotto PM; Holst JJ; Watt MJ
Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E835-E845. PubMed ID: 33645252
[TBL] [Abstract][Full Text] [Related]
13. The GDF3-ALK7 signaling axis in adipose tissue: a possible therapeutic target for obesity and associated diabetes?
Izumi T
Endocr J; 2023 Aug; 70(8):761-770. PubMed ID: 37081691
[TBL] [Abstract][Full Text] [Related]
14. Activin E enhances insulin sensitivity and thermogenesis by activating brown/beige adipocytes.
Sekiyama K; Ushiro Y; Kurisaki A; Funaba M; Hashimoto O
J Vet Med Sci; 2019 May; 81(5):646-652. PubMed ID: 30880304
[TBL] [Abstract][Full Text] [Related]
15.
Chávaro-Ortiz LI; Tapia BD; Rico-Hidalgo M; Gutiérrez-Aguilar R; Frigolet ME
Br J Nutr; 2022 Mar; 127(6):801-809. PubMed ID: 33958011
[TBL] [Abstract][Full Text] [Related]
16. C1q/TNF-related protein 2 (CTRP2) deletion promotes adipose tissue lipolysis and hepatic triglyceride secretion.
Lei X; Wong GW
J Biol Chem; 2019 Oct; 294(43):15638-15649. PubMed ID: 31439668
[TBL] [Abstract][Full Text] [Related]
17. Defective adipose lipolysis and altered global energy metabolism in mice with adipose overexpression of the lipolytic inhibitor G0/G1 switch gene 2 (G0S2).
Heckmann BL; Zhang X; Xie X; Saarinen A; Lu X; Yang X; Liu J
J Biol Chem; 2014 Jan; 289(4):1905-16. PubMed ID: 24302733
[TBL] [Abstract][Full Text] [Related]
18. Targeting activin receptor-like kinase 7 ameliorates adiposity and associated metabolic disorders.
Zhao M; Okunishi K; Bu Y; Kikuchi O; Wang H; Kitamura T; Izumi T
JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36626233
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte Glucocorticoid Receptor Deficiency Attenuates Aging- and HFD-Induced Obesity and Impairs the Feeding-Fasting Transition.
Mueller KM; Hartmann K; Kaltenecker D; Vettorazzi S; Bauer M; Mauser L; Amann S; Jall S; Fischer K; Esterbauer H; Müller TD; Tschöp MH; Magnes C; Haybaeck J; Scherer T; Bordag N; Tuckermann JP; Moriggl R
Diabetes; 2017 Feb; 66(2):272-286. PubMed ID: 27650854
[TBL] [Abstract][Full Text] [Related]
20. Impaired adipose tissue lipid storage, but not altered lipolysis, contributes to elevated levels of NEFA in type 2 diabetes. Degree of hyperglycemia and adiposity are important factors.
Pereira MJ; Skrtic S; Katsogiannos P; Abrahamsson N; Sidibeh CO; Dahgam S; Månsson M; Risérus U; Kullberg J; Eriksson JW
Metabolism; 2016 Dec; 65(12):1768-1780. PubMed ID: 27832864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
